Artini to Jointly Develop Big Healthcare Products With Guangzhou Baiyunshan Pharmaceutical Unit

MT Newswires Live

Sep 22

Retail chain operator Artini (HKG:0789) said it entered a preliminary agreement with Guangzhou Baiyunshan Wei Yi Industries to jointly develop products in the big healthcare sector, according to a Hong Kong bourse filing Friday.

Shares of the company gained 35% in late morning trade Monday.

Both sides will conduct research and development on products focused on the big healthcare sector, while supporting efforts to expand their market.

The partnership is subject to definitive agreements.

Guangzhou Baiyunshan is a unit of Guangzhou Baiyunshan Pharmaceutical (HKG:0874, SHA:600332).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2569820855"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569820855\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569820855?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-22 12:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569820855","market":"sg","top_or_hot":-1,"title":"Artini to Jointly Develop Big Healthcare Products With Guangzhou Baiyunshan Pharmaceutical Unit","media":"MT Newswires Live","content":"<html><body><p> Retail chain operator Artini (HKG:0789) said it entered a preliminary agreement with <a href=\"https://laohu8.com/S/GZPHF\">Guangzhou Baiyunshan</a> Wei Yi Industries to jointly develop products in the big healthcare sector, according to a Hong Kong bourse filing Friday.</p><p>Shares of the company gained 35% in late morning trade Monday.</p><p>Both sides will conduct research and development on products focused on the big healthcare sector, while supporting efforts to expand their market.</p><p>The partnership is subject to definitive agreements.</p><p><a href=\"https://laohu8.com/S/600332\">Guangzhou Baiyunshan</a> is a unit of Guangzhou Baiyunshan Pharmaceutical (HKG:0874, SHA:600332).</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Artini to Jointly Develop Big Healthcare Products With Guangzhou Baiyunshan Pharmaceutical Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArtini to Jointly Develop Big Healthcare Products With Guangzhou Baiyunshan Pharmaceutical Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-22 12:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Retail chain operator Artini (HKG:0789) said it entered a preliminary agreement with <a href=\"https://laohu8.com/S/GZPHF\">Guangzhou Baiyunshan</a> Wei Yi Industries to jointly develop products in the big healthcare sector, according to a Hong Kong bourse filing Friday.</p><p>Shares of the company gained 35% in late morning trade Monday.</p><p>Both sides will conduct research and development on products focused on the big healthcare sector, while supporting efforts to expand their market.</p><p>The partnership is subject to definitive agreements.</p><p><a href=\"https://laohu8.com/S/600332\">Guangzhou Baiyunshan</a> is a unit of Guangzhou Baiyunshan Pharmaceutical (HKG:0874, SHA:600332).</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600332","symbol_name":"白云山","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2569820855","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569820855","pubTimestamp":1758515840,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Retail chain operator Artini (HKG:0789) said it entered a preliminary agreement with Guangzhou Baiyunshan Wei Yi Industries to jointly develop products in the big healthcare sector, according to a Hon","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600332":"白云山","BK4585":"ETF&股票定投概念","BK1606":"中医药概念","BK1114":"服装零售","BK1515":"抗疫概念","BK0070":"员工持股","BK0196":"行业龙头","BK0097":"医药电商","HCSG":"Healthcare Svcs Group Inc","BK0239":"医药制造","BK1197":"保健护理产品经销商","XLV":"健康照护类股ETF-SPDR","BK0096":"民营医院","BK1521":"挪威政府全球养老基金持仓","00789":"雅天妮集团","BK1227":"服装、服饰与奢侈品","BK4588":"碎股","LABU":"三倍做多标普生物-Direxion","BK0183":"MSCI概念","XBI":"SPDR S&P Biotech ETF","BK0188":"融资融券","BK0012":"证金概念","00874":"白云山","BK0028":"国家队","BK4137":"综合支持服务","BK1191":"制药","BK0175":"白马股","BK4581":"高盛持仓"},"translate_title":"Artini将与广州白云山制药联合开发大健康产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":0.9,"00789":0.9,"00874":0.9,"HCSG":1.5,"LABU":0.6,"XBI":0.6,"XLV":1.5},"content_text":"Retail chain operator Artini (HKG:0789) said it entered a preliminary agreement with Guangzhou Baiyunshan Wei Yi Industries to jointly develop products in the big healthcare sector, according to a Hong Kong bourse filing Friday.Shares of the company gained 35% in late morning trade Monday.Both sides will conduct research and development on products focused on the big healthcare sector, while supporting efforts to expand their market.The partnership is subject to definitive agreements.Guangzhou Baiyunshan is a unit of Guangzhou Baiyunshan Pharmaceutical (HKG:0874, SHA:600332).","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}